Pfizer Sees Once Daily Danuglipron In The “Reasonable Future”

 
• By Jessica Merrill
  
scale
Pfizer updated investors on its GLP-1 agonist for weight loss • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category